Wag! Group Co.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PET research report →
Range $0.5 – $4
Price Chart
About the company
Wag! Group Co. manages and maintains an exclusive digital marketplace, available through both its website and a mobile application.
- CEO
- Garrett Smallwood
- IPO
- 2021
- Employees
- 64
- HQ
- San Francisco, NY, US
Get TickerSpark's AI analysis on PET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.38M
- P/E
- -0.22
- Fwd P/E
- 0.59
- PEG
- 0.01
- P/S
- 0.07
- P/B
- -0.30
- EV/EBITDA
- -2.86
- Div Yield
- 0.00%
- Gross Margin
- 91.46%
- Op Margin
- -26.29%
- Net Margin
- -34.61%
- ROE
- 192.30%
- ROIC
- -70.42%
Latest fiscal year · YoY change
- Revenue
- $70.51M-16.0%
- Gross Profit
- $65.22M-14.9%
- Op Income
- $-10,384,000
- Net Income
- $-17,568,000-31.9%
- EPS
- $-0.39-11.4%
- OCF Growth
- -8.3%
- FCF Growth
- -29.4%
- 52W High
- $1.16
- 52W Low
- $0.00
- 50D MA
- $0.13
- 200D MA
- $0.22
- Beta
- 1.26
- RSI (14)
- 55
- Avg Volume
- 9.10M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Wag! reported a smaller Q1 revenue base but improved efficiency, with management pointing to new distribution partnerships and stronger early Q2 momentum to support 2025 growth and profitability.· May 12, 2025
- Q1 revenue was $15.2 million and adjusted EBITDA loss was $1.2 million, both slightly lower than Q4, but management said profitability was ahead of expectations.
- Total costs and expenses fell 25% year over year by more than $6 million, reflecting tighter cost control and operational efficiencies.
- Three major distribution partners went live at the end of Q1 and are expected to begin contributing meaningfully to the insurance comparison business in Q2.
- Management said sales and marketing expense declined 34% year over year and that the company is deliberately reducing marketing spend while improving channel efficiency.
- Full-year 2025 guidance was reiterated at $84 million to $88 million of revenue and $2 million to $4 million of adjusted EBITDA.
Q1 revenue was $15.2 million and adjusted EBITDA loss was $1.2 million, both described as declining slightly versus Q4. Platform participants reached 472,000, up 6% sequentially. Revenue by category was services $4.9 million, wellness $9.2 million, and pet food and treats $1.1 million. Total cost and expenses were down 25% year over year by more than $6 million; cost of revenue was $1.4 million, or 10% of revenue; platform operations and support were $2.5 million, or 17% of revenue; sales and marketing was $10.4 million; and G&A was $4 million. The company ended Q1 with $11.7 million in cash and cash equivalents and accounts receivable. For 2025, management reiterated revenue guidance of $84 million to $88 million and adjusted EBITDA guidance of $2 million to $4 million.
Garrett Smallwood framed the quarter as a step forward on profitability despite lower year-over-year revenue, emphasizing disciplined cost management, operational efficiencies, and a more efficient customer acquisition strategy. He highlighted headcount streamlining, automation, and deeper AI integration as drivers of improved execution, and said the company is actively evaluating strategic options. He sounded constructive on growth, pointing to three major partners going live at quarter-end and strong trends in April and early May.
Alec Davidian said Q1 reflected improved operating efficiency and the early stages of scaling new opportunities and partners. He cited 472,000 platform participants, revenue of $15.2 million, an adjusted EBITDA loss of $1.2 million, and a 25% year-over-year decline in total costs and expenses. He also noted that cash and cash equivalents plus accounts receivable totaled $11.7 million at quarter-end, and said the Board is evaluating options that could strengthen the balance sheet and help reduce debt.
There was no real analyst Q&A segment in the transcript, so management’s most notable comments centered on guidance and strategic review. They reiterated 2025 revenue of $84 million to $88 million and adjusted EBITDA of $2 million to $4 million, while saying the board is assessing options that could be accretive to the balance sheet and reduce debt. Management also said the new distribution partners should start contributing meaningfully in Q2 and that early Q2 business trends have been strong.
The bull case is that Wag! is showing operating leverage: costs and expenses dropped materially, sales and marketing was down 34% year over year, and management said profitability came in ahead of expectations. The company also sees near-term growth support from three new distribution partners, with strong trends in April and early May suggesting acceleration in Q2.
The bear case is that revenue still declined year over year and Q1 adjusted EBITDA remained a loss. The company’s cash position was modest at $11.7 million in cash and receivables, and management said it is still evaluating balance-sheet options and debt reduction, which suggests financial flexibility remains a concern.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 49.8%
- Shares Outstanding
- 50.74M
- Float Shares
- 25.24M
of shares held by institutions
22 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 53.39K | ▲ 14.23K |
| Cowen And Company, LLC | 45.00K | 0 |
Held by 2 ETFs
Biggest fund positions in PET by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 15, 25 | SZABO JOHN P JR | sell | 1,670,000 |
| Jul 17, 25 | SZABO JOHN P JR | sell | 100,000 |
| Jul 17, 25 | SZABO JOHN P JR | sell | 500,000 |
| May 19, 25 | Cane David | other | 36,357 |
| May 19, 25 | McCarthy Patrick | other | 47,584 |
| May 19, 25 | Smallwood Garrett | other | 80,527 |
| May 19, 25 | Arjomand Maziar | other | 79,717 |
| May 19, 25 | Davidian Alec | other | 67,237 |
| May 19, 25 | Allread Dylan | other | 44,609 |
| May 19, 25 | Storm Adam | other | 62,026 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PET coverage
Recent articles, reports, and earnings notes.
No research on PET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PET report →Grey Matters Health taps ProScan for brain PET scan interpretation in Florida
proactiveinvestors.com · Aug 19
Grey Matters Health to open first NovaScan Neuroimaging Clinic in September
proactiveinvestors.com · Aug 4
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
globenewswire.com · Aug 4
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease
gurufocus.com · Jul 14
Grey Matters Health expands brain imaging services – ICYMI
proactiveinvestors.com · Jul 11
Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic
proactiveinvestors.com · Jul 6
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
globenewswire.com · Jul 6
Pet Valu Holdings Ltd. (PET) Closes the Market
newsfilecorp.com · Jun 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.